Lu Diao
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Immunotherapy and Immune Responses 6
-
- Nanoparticle-Based Drug Delivery 3
- Co-authors
- Mi Liu (11 shared papers)Jin Tao (6 shared papers)Ao Shen (3 shared papers)Yang Zhang (1 shared paper)Wenfei He (1 shared paper)Ying Hu (1 shared paper)Fengfeng Mo (3 shared papers)Yiqi Wang (1 shared paper)
- Journals
- Advanced Science (3 papers)iScience (2 papers)Advanced Materials (2 papers)International Journal of Nanomedicine (2 papers)RSC Advances (2 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Lu Diao
18 papers receiving 550 citations
Peers
Comparison fields: 5 of 55
- Immunology 193
- Biomaterials 94
- Molecular Medicine 39
- Pharmaceutical Science 33
- Drug Discovery 1
Countries citing papers authored by Lu Diao
This map shows the geographic impact of Lu Diao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Diao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Diao more than expected).
Fields of papers citing papers by Lu Diao
This network shows the impact of papers produced by Lu Diao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Diao. The network helps show where Lu Diao may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Diao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 113 | |
| 2 | 2023 | 106 | |
| 3 | 2020 | 92 | |
| 4 | 2019 | 47 | |
| 5 | 2020 | 34 | |
| 6 | 2018 | 26 | |
| 7 | 2022 | 22 | |
| 8 | 2019 | 20 | |
| 9 | 2023 | 20 | |
| 10 | 2022 | 18 | |
| 11 | 2025 | 17 | |
| 12 | 2022 | 14 | |
| 13 | 2021 | 10 | |
| 14 | 2021 | 8 | |
| 15 | 2025 | 4 | |
| 16 | 2025 | 2 | |
| 17 | 2023 | 1 | |
| 18 | 2025 | 1 |
About Lu Diao
Lu Diao is a scholar working on Immunology, Biomaterials, Pharmaceutical Science, Molecular Biology and Oncology, having authored 18 papers that have together received 555 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), RNA Interference and Gene Delivery (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Advanced Drug Delivery Systems (2 papers), Acute Ischemic Stroke Management (1 paper), Orthopedic Infections and Treatments (1 paper), Bone Tissue Engineering Materials (1 paper) and Advanced biosensing and bioanalysis techniques (1 paper). The work is most often cited by research in Immunology (193 citations), Biomaterials (94 citations), Molecular Medicine (39 citations), Pharmaceutical Science (33 citations) and Drug Discovery (1 citation). Lu Diao has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Mi Liu, Jin Tao, Ao Shen, Yang Zhang, Wenfei He, Ying Hu, Fengfeng Mo, Yiqi Wang, Xuenong Zhang and Guoqiang Xu. Their work appears in journals such as Advanced Science, iScience, Advanced Materials, International Journal of Nanomedicine and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.